Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
3
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
3
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
ceo
commissioner
fda
gene editing
indiana blog main
indiana top stories
ipo
scott gottlieb
shutdown
abbvie
ac immune
acquisition
advaxis
aimmune therapeutics
alder biopharmaceuticals
What
bio
medicine
3
×
roundup
3
×
ask
big
biopharma
bosley's
bosley’s
bridge
bucks
car
cas
celgene
ceo
colleagues
congrats
crime
crispr
departure
editas
effect
exit
exome
government
guiding
health
honored
hundreds
icer’s
industry
isn't
katrine
moves
nobel
personnel
placebo
policy
prize
prizes
published
Language
unset
Current search:
roundup
×
" boston top stories "
×
" seattle blog main "
×
medicine
×
@xconomy.com
4 years ago
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More